China Orthopedic Instrument Industry Report, 2009-2010
  • Nov/2010
  • Hard Copy
  • USD $1,600
  • Pages:59
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZT001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,500
  • Hard Copy + Single User License
  • USD $1,800
Benefiting from population aging, consumption upgrading and policy support, the orthopedic instrument industry has witnessed rapid development in recent years. The annual compound growth rate during 2006-2009 was as high as 22.1%, and the market size in 2009 reached RMB6 billion. Joint, trauma and vertebral column products, the three major products in Chinese orthopedic instrument market, achieved market size of RMB1.8 billion, RMB1.67 billion and RMB1.49 billion respectively in 2009.

Market Size and Growth Rate, 2006-2009 (RMB bn)
Source: China Orthopaedics; ResearchInChina

Subject to R&D and production technology constraints, Chinese orthopedic instrument market is mainly dominated by foreign-funded enterprises (with 56% market share in 2009), including Johnson & Johnson, Medtronic, Synthes, and Stryker. However, by virtue of such advantages as low production cost, mature manufacturing technology, and sound medical marketing channels, local enterprises are scrambling for larger share in the orthopedic instrument market and heading towards the high-end market form low and medium-end market, so, the future will see an evident trend of import products being replaced with domestic products. Trauson Holdings, Kanghui Medical and Weigao Group, the three major domestic enterprises, in particular, held an accumulative total of 17.1% in trauma product market and 13.7% in vertebral column product market in 2009, indicating powerful market competitiveness.  

Take Trauson Holdings as an example. In 2009, the company obtained total revenue of RMB211 million, up 21.3% from 2008, hereinto, trauma products realized revenue of RMB135 million and held 8% of the domestic trauma product market, only second to Synthes; vertebral column products made revenue of RMB31 million and occupied 3% of the domestic vertebral column product market, ranking the 6th.  

Operating Income and Gross Margin of Trauson Holdings, 2007-2010 (RMB mln)
Source: company annual report; ResearchInChina

Trauson Holdings is strengthening production, sales, M&A, and the R&D of new products so as to improve the core competitiveness. In June 2010, the company planned to invest the RMB520 million raised through public offering in capacity expansion and equipment upgrading (about RMB200 million), product R&D, market expansion and marketing channel construction (approximately RMB100 million), and M&A (roughly RMB180 million). Up to June 2010, besides the existing 88 kinds of orthopedic products, Trauson Holdings was engaged in the R&D of 11 new products as well as the clinical test of 7 new products, including 5 vertebral column products and 2 joint products; its new factory in Changzhou was under construction according to schedule and was anticipated to be completed by the end of Dec. 2010; adding 40 new distributors, the company expanded the total number of distributors to 430, including 51 overseas distributors.
1. Overview of Orthopedic Instrument Industry
1.1 Definition and Classification 
1.2 Industrial Chain 

2. Overview of Chinese Orthopedic Instrument Industry
2.1 Profile 
2.2 Operating Environment 
2.2.1 International Environment 
2.2.2 Policy Environment 
2.3 Market 
2.3.1 Status Quo 
2.3.2 Market Size and Gross Profit 
2.3.3 Supply and Demand 
2.3.4 Segmented Market 
2.3.5 Competition Pattern 
2.3.6 Marketing Channel 
2.3.7 Forecast 
2.4 Risk 
2.4.1 Regulation Risk
2.4.2 Medical Malpractice Lawsuit & Compensation 

3. Import and Export of Chinese Orthopedic Instrument Industry
3.1 Import and Export 
3.1.1 Import 
3.1.2 Export 
3.1.3 Comparison between Import and Export 
3.2 Import & Export of Trauma and Vertebral Column Products
3.2.1 Import 
3.2.2 Export 
3.2.3 Comparison between Import and Export
3.3 Import & Export of Artificial Joint Products 
3.3.1 Import 
3.3.2 Export 
3.3.3 Comparison between Import and Export

4. Major Orthopedic Instrument Manufacturers in Chinese Market 
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson
4.1.2 Johnson & Johnson (China) and Johnson & Johnson Medical (Suzhou) Ltd.
4.2 Medtronic
4.2.1 Profile 
4.2.2 Operation in China 
4.3 Trauson Holdings
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Business Development 
4.4 KangHui Medical 
4.4.1 Profile 
4.4.2 Operation 
4.4.3 Business Development
4.5 Weigao Group
4.5.1 Weigao Group
4.5.2 Weigao Orthopaedic
4.5.3 Medtronic Weigao Orthopaedic Device Company Limited
4.6 Xinrong Best
4.6.1 Profile 
4.6.2 Operation 
4.6.3 Business Development
4.7 Walkman
4.7.1 Profile 
4.7.2 Operation 
4.7.3 Business Innovation 
4.8 Montagne
4.8.1 Profile 
4.8.2 Operation 
4.8.3 Business Development
4.9 LDK
4.9.1 Profile 
4.9.2 Operation 
4.10 Renli
4.10.1 Profile 
4.10.2 Operation 
Classification and Materials of Orthopedic Instrument 
Orthopedic Instrument Industrial Chain 
Chinese Medical Device Market Size and Growth Rate, 2002-2009 
Chinese Orthopedic Instrument Market Size and Growth Rate, 2006-2009 
Global Orthopedic Instrument Market Size, 2003-2015E
Global Orthopedic Instrument Market Share by Region, 2009 
Orthopedic Product Sales and Proportion of Top 6 Orthopedic Instrument Magnates, 2007-2009 
Investment in China by Global Orthopedic Instrument Enterprises  
China’s Major Laws and Regulations concerning Medical Device Industry  
Relevant Policies of Orthopedic Instrument Industry 
Major Orthopedic Instrument Manufacturers in China  
Gross Margin of Major Orthopedic Instrument Manufacturers in China, 2007-2009 
Population and Proportion of People Aged 65 or above by Country, 2010  
Arthritis Patient Population by Country, 2008
Orthopedic Instrument Segmented Market Size in China, 2006-2009 
Proportion of Domestically-funded Enterprises and Foreign-funded Enterprises in Chinese Orthopedic Instrument Market & Segmented Market, 2009 
Market Share of Trauma Product Manufacturers in China, 2009 
Market Share of Vertebral Column Product Manufacturers in China, 2009 
Approval Flow of 2.5-3.5-Year Product Registration Certificate 
Chinese Orthopedic Instrument Marketing Channels 
Market Share of Orthopedic Products, Global vs. China, 2008 
Import Volume of Orthopedic Instrument in China, 2009-Sep.2010 
Import Value of Orthopedic Instrument in China, 2009-Sep.2010  
Export Volume of Orthopedic Instrument in China, 2009-Sep.2010   
Export Value of Orthopedic Instrument in China, 2009-Sep.2010    
Import & Export Volume of Orthopedic Instrument in China, Oct.2009 –Sep.2010 
Import & Export Value of Orthopedic Instrument in China, Oct.2009 –Sep.2010   
Import Volume of Trauma and Vertebral Column Products in China, 2009-Sep.2010 
Import Value of Trauma and Vertebral Column Products in China, 2009-Sep.2010   
Export Volume of Trauma and Vertebral Column Products in China, 2009-Sep.2010    
Export Value of Trauma and Vertebral Column Products in China, 2009-Sep.2010    
Import & Export Volume of Trauma and Vertebral Column Products in China, Oct.2009 –Sep.2010    
Import & Export Value of Trauma and Vertebral Column Products in China, Oct.2009 –Sep.2010  
Import Volume of Artificial Joint Products in China, 2009-Sep.2010    
Import Value of Artificial Joint Products in China, 2009-Sep.2010    
Export Volume of Artificial Joint Products in China, 2009-Sep.2010    
Export Value of Artificial Joint Products in China, 2009-Sep.2010    
Import & Export Volume of Artificial Joint Products in China, Oct.2009 –Sep.2010   
Import & Export Value of Artificial Joint Products in China, Oct.2009 –Sep.2010   
Johnson & Johnson Total Revenue and Revenue & Proportion of Medical Device Division and Orthopedics Division, 2006-2009 
Medtronic Annual Revenue and Revenue & Proportion of Orthopedic Business, FY2007-FY2010 
Operating Income and Gross Margin of Trauson Holdings, 2007-2010  
Domestic and International Market Revenue of Orthopedic Products of Trauson Holdings, 2007-2009 
Orthopedic Product Capacity of Trauson Holdings, 2007-2010 
Operating Income and Gross Margin of KangHui Medical, 2007-2010 
Domestic and International Market Revenue of KangHui Medical, 2007-2009 
Total Revenue of Weigao Group and Revenue & Proportion of Orthopedics Division, 2006-2010 
Operating Income and Gross Margin of Weigao Orthopaedic, 2007-2010 
Weigao Orthopaedic Product Output, 2007-2010  
Operating Income of Medtronic Weigao Orthopaedic Device Company Limited, 2009-2010 
Operating Income and Gross Margin of Xinrong Best, 2005-2008  
Operating Income and Gross Margin of Walkman, 2005-2008 
Revenue and Net Profit Margin of Montagne, 2007-2009  
Operating Income and Gross Margin of LDK, 2007-2008 
Operating Income and Gross Margin of Renli, 2005-2008  

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号